Julien Capers
Consejero General en VERA THERAPEUTICS, INC. .
Cargos activos de Julien Capers
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| VERA THERAPEUTICS, INC. | Consejero General | 01/09/2022 | - |
Historial de carrera de Julien Capers
Antiguos cargos conocidos de Julien Capers.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ZOGENIX, INC. | Corporate Officer/Principal | - | - |
Formación de Julien Capers.
| Stanford University | Undergraduate Degree |
| UC Davis School of Law | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| General Counsel | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| VERA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Julien Capers
- Experiencia
